ContractDevelopment and Licence Agreement • February 25th, 2009 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances)
[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
